Inhibition of Rho-associated coiled-coil-forming kinase increases efficacy of measles virotherapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Rho-associated coiled-coil-forming kinase increases efficacy of measles virotherapy
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume 20, Issue 11, Pages 630-637
Publisher
Springer Nature
Online
2013-10-25
DOI
10.1038/cgt.2013.58
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RKI-1447 Is a Potent Inhibitor of the Rho-Associated ROCK Kinases with Anti-Invasive and Antitumor Activities in Breast Cancer
- (2012) R. A. Patel et al. CANCER RESEARCH
- Oncolytic measles virus strains have significant antitumor activity against glioma stem cells
- (2012) C Allen et al. GENE THERAPY
- Nectin-4-Dependent Measles Virus Spread to the Cynomolgus Monkey Tracheal Epithelium: Role of Infected Immune Cells Infiltrating the Lamina Propria
- (2012) M. Frenzke et al. JOURNAL OF VIROLOGY
- Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma
- (2012) A. W. Studebaker et al. NEURO-ONCOLOGY
- Cooperative Anti-Invasive Effect of Cdc42/Rac1 Activation and ROCK Inhibition in SW620 Colorectal Cancer Cells with Elevated Blebbing Activity
- (2012) Marion de Toledo et al. PLoS One
- Causes of Mortality after Liver Transplantation: A Single Center Experience in Mainland China
- (2011) Lin Xu et al. HEPATO-GASTROENTEROLOGY
- Effective Radiovirotherapy for Malignant Gliomas by Using Oncolytic Measles Virus Strains Encoding the Sodium Iodide Symporter (MV-NIS)
- (2011) Mateusz Opyrchal et al. HUMAN GENE THERAPY
- The heads of the measles virus attachment protein move to transmit the fusion-triggering signal
- (2011) Chanakha K Navaratnarajah et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
- (2010) E. Galanis et al. CANCER RESEARCH
- Treatment of medulloblastoma with a modified measles virus
- (2010) A. W. Studebaker et al. NEURO-ONCOLOGY
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- The actin cytoskeleton inhibits pore expansion during PIV5 fusion protein-promoted cell–cell fusion
- (2010) Mark A. Wurth et al. VIROLOGY
- Chagas Disease Risk in Texas
- (2010) Sahotra Sarkar et al. PLoS Neglected Tropical Diseases
- Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model
- (2009) Ianko D. Iankov et al. BREAST CANCER RESEARCH AND TREATMENT
- Viral entry mechanisms: the increasing diversity of paramyxovirus entry
- (2009) Everett C. Smith et al. FEBS Journal
- Glycoprotein interactions in paramyxovirus fusion
- (2009) Ronald M Iorio et al. Future Virology
- Noninvasive Imaging and Radiovirotherapy of Prostate Cancer Using an Oncolytic Measles Virus Expressing the Sodium Iodide Symporter
- (2009) Pavlos Msaouel et al. MOLECULAR THERAPY
- Converting Tumor-specific Markers Into Reporters of Oncolytic Virus Infection
- (2009) Ianko D Iankov et al. MOLECULAR THERAPY
- Oncolytic measles virus strains in the treatment of gliomas
- (2008) Cory Allen et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Interleukin-13 Displaying Retargeted Oncolytic Measles Virus Strains Have Significant Activity Against Gliomas With Improved Specificity
- (2008) Cory Allen et al. MOLECULAR THERAPY
- Engineered measles virus as a novel oncolytic therapy against prostate cancer
- (2008) Pavlos Msaouel et al. PROSTATE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started